Mulrenin v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedJanuary 4, 2021
Docket18-22
StatusUnpublished

This text of Mulrenin v. Secretary of Health and Human Services (Mulrenin v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mulrenin v. Secretary of Health and Human Services, (uscfc 2021).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 18-22V Filed: December 10, 2020 UNPUBLISHED

SUZANNE MULRENIN, on behalf of Special Master Horner her minor child, R.M.,

Petitioner, Interim Attorneys’ Fees and v. Costs Decision; Expert Costs; Reasonable Hourly Rate SECRETARY OF HEALTH AND HUMAN SERVICES,

Respondent.

Andrew Donald Downing, Van Cott & Talamante, PLLC, Phoenix, AZ, for petitioner. Darryl R. Wishard, U.S. Department of Justice, Washington, DC, for respondent.

DECISION AWARDING INTERIM ATTORNEYS’ FEES AND COSTS1

On September 1, 2020, petitioner moved for an award of interim attorneys’ fees and costs in the amount of $67,886.16. (ECF No. 45.) In response, respondent deferred to the special master regarding both the amount and appropriateness of an award of interim attorneys’ fees and costs. (ECF No. 46.) However, respondent did note that “respondent is satisfied the statutory requirements and other legal requirements for an award of attorneys’ fees and costs are met.” (Id. at 2.) For the reasons discussed below, I award petitioner interim attorneys’ fees and costs in reduced amount of $65,321.16.

I. Procedural History

On January 4, 2018, petitioner filed a petition under the National Childhood Vaccine Injury Act, 42 U.S.C. § 300aa-10-34 (2012), alleging that her minor child, R.M.,

1 Because this decision contains a reasoned explanation for the special master’s action in this case, it will be posted on the United States Court of Federal Claims’ website in accordance with the E-Government Act of 2002. See 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information the disclosure of which would constitute an unwarranted invasion of privacy. If the special master, upon review, agrees that the identified material fits within this definition, it will be redacted from public access. experienced post-vaccination symptoms later diagnosed as a Mast Cell Activation Syndrome (“MCAS”), caused or significantly aggravated by her November 16, 2015 influenza (“flu”) vaccination. (ECF No. 1.)

This case was originally assigned to Special Master Millman. (ECF No. 4.) Petitioners filed records to a support her claim and a Statement of Completion. (ECF Nos. 6-9, 11, 13, 14.) Thereafter, respondent filed his Rule 4(c) report, recommending against compensation on May 17, 2018. (ECF No. 19.)

Petitioner then filed an expert report from Dr. Jonathan A. Bernstein, allergist and immunologist. (ECF No. 21.) In response, respondent filed an expert report from Dr. Andrew J. MacGinnitie. (ECF No. 24.) This case was reassigned to my docket on June 5, 2019. (ECF No. 30.) Subsequently, I held a status conference and asked the parties to file a round of supplemental reports from their respective experts.

On January 20, 2020, petitioner filed a supplemental report from Dr. Bernstein and on February 24, 2020, respondent filed a supplemental report from Dr. MacGinnitie. (ECF Nos. 34, 37.) Thereafter, petitioner proposed resolving this case based on the written record and respondent had no objection. (ECF No. 38.) On June 12, 2020, petitioner moved for a decision on the record, on July 31, 2020, respondent filed his response, and on August 7, 2020, petitioner filed a reply. (ECF Nos. 41-42, 44.)

Petitioner filed the instant motion for interim attorneys’ fees and costs on September 1, 2020, respondent filed his response on September 8, 2020, and petitioner did not file a reply. (ECF Nos. 45-46.) Accordingly, petitioner’s motion for interim attorneys’ fees and costs is now ripe for resolution.

II. An Award of Interim Attorneys’ Fees and Costs is Appropriate

Section 15(e)(1) of the Vaccine Act allows for the special master to award “reasonable attorneys' fees, and other costs.” § 300aa–15(e)(1)(A)–(B). Petitioners are entitled to an award of reasonable attorneys' fees and costs if they are entitled to compensation under the Vaccine Act, or, even if they are unsuccessful, if the special master finds that the petition was filed in good faith and with a reasonable basis. Avera v. Sec'y of Health & Human Servs., 515 F.3d 1343, 1352 (Fed. Cir. 2008). In his response, respondent indicated that the statutory requirements were met in this case. (ECF No. 46, p. 2.) I agree.

Additionally, the Federal Circuit has concluded that interim fee awards are permissible and appropriate under the Vaccine Act. Shaw v. Sec’y of Health & Human Servs., 609 F.3d 1372 (Fed. Cir. 2010); Avera, 515 F.3d at 1352. In Avera, the Federal Circuit stated, “[i]nterim fees are particularly appropriate in cases where proceedings are protracted and costly experts must be retained.” Id. In denying an interim fee award, the Avera court reasoned, “The amount of fees here was not substantial; appellants had not employed any experts; and there was only a short delay in the award pending the appeal.” Id. In Shaw, the Federal Circuit clarified that “where the claimant

2 establishes that the cost of litigation has imposed an undue hardship and there exists a good faith basis for the claim, it is proper for the special master to award interim attorneys’ fees.” 609 F.3d at 1375. Here, petitioner’s request for interim attorneys’ fees and costs is made after more than two years of litigation within the entitlement phase of this case and after petitioner incurred costs for providing multiple expert reports to support her claim.

III. Reasonableness of the Requested Award

a. Attorneys’ Fees

It is “well within the special master’s discretion” to determine the reasonableness of fees. Saxton v. Sec’y of Health & Human Servs., 3 F.3d 1517, 1521-22 (Fed. Cir. 1993); see also Hines v. Sec’y of Health & Human Servs., 22 Cl. Ct. 750, 753 (1991) (“[T]he reviewing court must grant the special master wide latitude in determining the reasonableness of both attorneys’ fees and costs.”). The Federal Circuit has approved the lodestar approach to determine reasonable attorneys’ fees and costs under the Vaccine Act. Avera, 515 F.3d at 1347. This is a two-step process. Id. at 1347-48. First, a court determines an “initial estimate…by ‘multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.’” Id. (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). Second the court may make an upward or downward departure from the initial calculation of the fee award based on specific findings. Id. at 1348.

A reasonable hourly rate is “the prevailing market rate defined as the rate prevailing in the community for similar services by lawyers of reasonably comparable skill, experience, and reputation.” Avera, 515 F.3d at 1348 (citation and quotation omitted). The decision in McCulloch provides a further framework for consideration of appropriate ranges for attorneys’ fees based upon the experience of the practicing attorney. McCulloch v. Sec’y of Health & Human Servs., No. 09-293V, 2015 WL 5634323, at *19 (Fed. Cl. Spec. Mstr. Sept.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Mulrenin v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mulrenin-v-secretary-of-health-and-human-services-uscfc-2021.